• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保健系统中的可持续性挑战:乳腺癌不适当治疗模式的频率和成本(E.Pic.A研究)

The challenge of sustainability in healthcare systems: Frequency and cost of inappropriate patterns of breast cancer care (the E.Pic.A study).

作者信息

Massa Ilaria, Balzi William, Burattini Costanza, Gentili Nicola, Bucchi Lauro, Nanni Oriana, Gallegati Davide, Pierini Andrea, Amadori Dino, Falcini Fabio, Altini Mattia

机构信息

Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via P. Maroncelli 40, 47014 Meldola, FC, Italy.

Healthcare Administration, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via P. Maroncelli 40, 47014 Meldola, FC, Italy.

出版信息

Breast. 2017 Aug;34:103-107. doi: 10.1016/j.breast.2017.05.007. Epub 2017 May 27.

DOI:10.1016/j.breast.2017.05.007
PMID:28558338
Abstract

OBJECTIVES

In a context of decreasing economic health resources and a rise in health needs, it is urgent to face this sustainability crisis through the analysis of healthcare expenditures. Wastages, deriving from inappropriate interventions, erode resources which could be reallocated to high-value activities. To identify these areas of wastages, we developed a method for combining and analyzing data from multiple sources. Here we report the preliminary results of a retrospective cohort study evaluating the performance of breast cancer (BC) care at IRST, an Italian cancer institute.

MATERIALS AND METHODS

Four data sources gathered in a real-world setting (a clinical database, two administrative databases and a cancer registry) were linked. Essential Key Performance Indexes (KPIs) in the pattern of BC diagnosis (KPI 1 and 2) and treatment (KPI 3 and 4) based on current guidelines were developed by a board of professionals. The costs of inappropriate examinations were associated with the diagnostic KPIs.

RESULTS

We found that 2798 patients treated at IRST from January 2010 to June 2016 received a total of 2516 inappropriate examinations accounting for € 573,510.80. Linkage from multiple routine healthcare data sources is feasible: it allows the measurement of important KPIs specifically designed for BC care, and the identification of areas of low-value use of the resources.

CONCLUSION

If systematically applied, this method could help provide a complete picture of inappropriateness and waste, redirect these resources to higher-value interventions for patients, and fill the gap between proper use of the resources and the best clinical results.

摘要

目标

在经济卫生资源减少而卫生需求增加的背景下,迫切需要通过分析医疗保健支出来应对这一可持续性危机。因不适当干预产生的浪费侵蚀了可重新分配用于高价值活动的资源。为了确定这些浪费领域,我们开发了一种整合和分析来自多个来源数据的方法。在此,我们报告一项回顾性队列研究的初步结果,该研究评估了意大利癌症研究所IRST的乳腺癌(BC)护理绩效。

材料与方法

将在真实环境中收集的四个数据源(一个临床数据库、两个行政数据库和一个癌症登记处)进行关联。由专业人员委员会根据当前指南制定了BC诊断模式(关键绩效指标1和2)和治疗(关键绩效指标3和4)中的基本关键绩效指标。不适当检查的费用与诊断关键绩效指标相关联。

结果

我们发现,2010年1月至2016年6月在IRST接受治疗的2798例患者共接受了2516次不适当检查,费用为573,510.80欧元。从多个常规医疗保健数据源进行关联是可行的:它能够衡量专门为BC护理设计的重要关键绩效指标,并确定资源低价值使用的领域。

结论

如果系统应用这种方法,有助于全面了解不适当和浪费情况,将这些资源重新导向为患者提供的更高价值干预措施,并填补资源合理使用与最佳临床结果之间的差距。

相似文献

1
The challenge of sustainability in healthcare systems: Frequency and cost of inappropriate patterns of breast cancer care (the E.Pic.A study).医疗保健系统中的可持续性挑战:乳腺癌不适当治疗模式的频率和成本(E.Pic.A研究)
Breast. 2017 Aug;34:103-107. doi: 10.1016/j.breast.2017.05.007. Epub 2017 May 27.
2
Patterns of care and cost profiles of women with breast cancer in Italy: EPICOST study based on real world data.意大利乳腺癌女性的护理模式和成本特征:基于真实世界数据的 EPICOST 研究。
Eur J Health Econ. 2020 Sep;21(7):1003-1013. doi: 10.1007/s10198-020-01190-z. Epub 2020 May 12.
3
The Breast Health Global Initiative: clinical practice guidelines for management of breast cancer in low- and middle-income countries.全球乳腺癌倡议:低收入和中等收入国家乳腺癌管理临床实践指南
Expert Rev Anticancer Ther. 2007 Aug;7(8):1095-104. doi: 10.1586/14737140.7.8.1095.
4
Health Expenditure and All-Cause Mortality in the 'Galaxy' of Italian Regional Healthcare Systems: A 15-Year Panel Data Analysis.意大利区域医疗保健系统“星系”中的卫生支出与全因死亡率:一项为期 15 年的面板数据分析。
Appl Health Econ Health Policy. 2017 Dec;15(6):773-783. doi: 10.1007/s40258-017-0342-x.
5
How much of US health care spending provides direct care or benefit to patients?美国医疗保健支出中有多少用于为患者提供直接护理或获益?
Cancer. 2019 May 1;125(9):1404-1409. doi: 10.1002/cncr.31865. Epub 2019 Jan 29.
6
[Macro-economic calculation of spending versus micro-economic follow-up of costs of breast cancer].[乳腺癌支出的宏观经济计算与成本的微观经济跟踪]
Rev Epidemiol Sante Publique. 2002 Dec;50(6):581-92.
7
Cost of breast cancer based on real-world data: a cancer registry study in Italy.基于真实世界数据的乳腺癌成本:意大利的一项癌症登记研究
BMC Health Serv Res. 2017 Jan 26;17(1):84. doi: 10.1186/s12913-017-2006-9.
8
Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry.美国管理式医疗癌症注册中心中三阴性乳腺癌患者的诊断后生存状况和医疗保健利用成本。
Curr Med Res Opin. 2012 Mar;28(3):419-28. doi: 10.1185/03007995.2011.628649. Epub 2012 Feb 24.
9
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study.常规循环生物标志物评估在早期乳腺癌中的适宜性和经济学分析:E.Pic.A 研究的真实世界经验。
Curr Oncol. 2022 Jan 18;29(2):433-438. doi: 10.3390/curroncol29020039.
10
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.资源有限国家的乳腺癌:《2005年全球乳腺癌防治倡议》指南概述
Breast J. 2006 Jan-Feb;12 Suppl 1:S3-15. doi: 10.1111/j.1075-122X.2006.00199.x.

引用本文的文献

1
Artificial-Intelligence Cloud-Based Platform to Support Shared Decision-Making in the Locoregional Treatment of Breast Cancer: Protocol for a Multidimensional Evaluation Embedded in the CINDERELLA Clinical Trial.基于人工智能云平台支持乳腺癌局部区域治疗的共同决策:灰姑娘临床试验中多维评估方案
Pharmacoecon Open. 2024 Nov;8(6):945-959. doi: 10.1007/s41669-024-00519-1. Epub 2024 Sep 12.
2
Cost of Low-Value Imaging Worldwide: A Systematic Review.全球低价值影像检查的成本:一项系统评价。
Appl Health Econ Health Policy. 2024 Jul;22(4):485-501. doi: 10.1007/s40258-024-00876-2. Epub 2024 Mar 1.
3
Cancer cost profiles: The Epicost estimation approach.
癌症成本概况:Epicost 估算方法。
Front Public Health. 2022 Sep 21;10:974505. doi: 10.3389/fpubh.2022.974505. eCollection 2022.
4
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study.常规循环生物标志物评估在早期乳腺癌中的适宜性和经济学分析:E.Pic.A 研究的真实世界经验。
Curr Oncol. 2022 Jan 18;29(2):433-438. doi: 10.3390/curroncol29020039.
5
The Challenge of Sustainability of High-Cost Oncological Drugs: A Budgeting Model in an Italian Cancer Center.高成本肿瘤药物可持续性挑战:意大利癌症中心的预算模型。
Int J Environ Res Public Health. 2021 Dec 20;18(24):13413. doi: 10.3390/ijerph182413413.
6
Effects of Lean Thinking and Emerging Technologies on Breast Cancer Patients' Therapeutic Process During COVID-19 Pandemic: A Case-Control Matched Study.精益思维与新兴技术对新冠疫情期间乳腺癌患者治疗过程的影响:一项病例对照匹配研究
Front Surg. 2021 Mar 11;8:582980. doi: 10.3389/fsurg.2021.582980. eCollection 2021.
7
Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China.不同外科治疗方法治疗早期乳腺癌的成本效果分析:来自中国的回顾性匹配队列研究。
BMC Cancer. 2021 Feb 2;21(1):107. doi: 10.1186/s12885-021-07840-6.
8
Assessment of Cancer Care Costs in Disease-Specific Cancer Care Pathways.疾病特异性癌症护理路径中的癌症护理成本评估。
Int J Environ Res Public Health. 2020 Jul 2;17(13):4765. doi: 10.3390/ijerph17134765.
9
The challenge of sustainability in healthcare systems: frequency and cost of diagnostic procedures in end-of-life cancer patients.医疗系统可持续性面临的挑战:临终癌症患者诊断程序的频率和成本。
Support Care Cancer. 2018 Jul;26(7):2201-2208. doi: 10.1007/s00520-018-4067-7. Epub 2018 Feb 1.